TY - JOUR A1 - Foti, Alessandro A1 - Dorendorf, Frank A1 - Leimkühler, Silke T1 - A single nucleotide polymorphism causes enhanced radical oxygen species production by human aldehyde oxidase JF - PLoS one N2 - Aldehyde oxidases (AOXs) are molybdo-flavoenzymes characterized by broad substrate specificity, oxidizing aromatic/aliphatic aldehydes into the corresponding carboxylic acids and hydroxylating various heteroaromatic rings. The enzymes use oxygen as the terminal electron acceptor and produce reduced oxygen species during turnover. The physiological function of mammalian AOX isoenzymes is still unclear, however, human AOX (hAOX1) is an emerging enzyme in phase-I drug metabolism. Indeed, the number of xenobiotics acting as hAOX1 substrates is increasing. Further, numerous single-nucleotide polymorphisms (SNPs) have been identified within the hAOX1 gene. SNPs are a major source of inter-individual variability in the human population, and SNP-based amino acid exchanges in hAOX1 reportedly modulate the catalytic function of the enzyme in either a positive or negative fashion. In this report we selected ten novel SNPs resulting in amino acid exchanges in proximity to the FAD site of hAOX1 and characterized the purified enzymes after heterologous expression in Escherichia coli. The hAOX1 variants were characterized carefully by quantitative differences in their ability to produce superoxide radical. ROS represent prominent key molecules in physiological and pathological conditions in the cell. Our data reveal significant alterations in superoxide anion production among the variants. In particular the SNP-based amino acid exchange L438V in proximity to the isoalloxanzine ring of the FAD cofactor resulted in increased rate of superoxide radical production of 75%. Considering the high toxicity of the superoxide in the cell, the hAOX1-L438V SNP variant is an eventual candidate for critical or pathological roles of this natural variant within the human population. Y1 - 2017 U6 - https://doi.org/10.1371/journal.pone.0182061 SN - 1932-6203 VL - 12 SP - 18338 EP - 18347 PB - PLoS CY - San Fransisco ER - TY - JOUR A1 - Volk, Christin A1 - Brandsch, Corinna A1 - Schlegelmilch, Ulf A1 - Wensch-Dorendorf, Monika A1 - Hirche, Frank A1 - Simm, Andreas A1 - Gargum, Osama A1 - Wiacek, Claudia A1 - Braun, Peggy G. A1 - Kopp, Johannes F. A1 - Schwerdtle, Tanja A1 - Treede, Hendrik A1 - Stangl, Gabriele I. T1 - Postprandial metabolic response to rapeseed protein in healthy subjects JF - Nutrients N2 - Plant proteins have become increasingly important for ecological reasons. Rapeseed is a novel source of plant proteins with high biological value, but its metabolic impact in humans is largely unknown. A randomized, controlled intervention study including 20 healthy subjects was conducted in a crossover design. All participants received a test meal without additional protein or with 28 g of rapeseed protein isolate or soy protein isolate (control). Venous blood samples were collected over a 360-min period to analyze metabolites; satiety was assessed using a visual analog scale. Postprandial levels of lipids, urea, and amino acids increased following the intake of both protein isolates. The postprandial insulin response was lower after consumption of the rapeseed protein than after intake of the soy protein (p< 0.05), whereas the postmeal responses of glucose, lipids, interleukin-6, minerals, and urea were comparable between the two protein isolates. Interestingly, the rapeseed protein exerted stronger effects on postprandial satiety than the soy protein (p< 0.05). The postmeal metabolism following rapeseed protein intake is comparable with that of soy protein. The favorable effect of rapeseed protein on postprandial insulin and satiety makes it a valuable plant protein for human nutrition. KW - rapeseed protein KW - soy protein KW - postprandial study KW - metabolic response KW - healthy subjects Y1 - 2020 U6 - https://doi.org/10.3390/nu12082270 SN - 2072-6643 VL - 12 IS - 8 PB - MDPI CY - Basel ER -